IP Verse

Glaxo Group patent opposition analysis

Get complete Patent Opposition Report for Glaxo Group

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Glaxo Group

Explore patent oppositions filed by Glaxo Group against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3459578Dispensing DevicePFIZERDec 2, 2021
EP3057612Method Of Obtaining Thermostable Dried Vaccine FormulationsMERCK SHARP & DOHMEFeb 5, 2021
EP2266549Method Of Making Particles For Use In A Pharmaceutical CompositionVECTURAMay 6, 2020
EP2298279Pharmaceutical Compositions For InhalationVECTURAAug 12, 2019
EP2752216Dispensing DevicePFIZERJul 19, 2019
EP2708558Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 18, 2018
EP2708559Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 18, 2018
EP2188371Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In BioreactorsWYETHSep 20, 2018
EP2586788Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHAug 27, 2018
EP2283818Method Of Making Particles For Use In A Pharmaceutical CompositionVECTURAMay 1, 2018

Latest patents of Glaxo Group opposed by its competitors

Explore Glaxo Group's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3578169Jun 26, 2024Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol1
EP3335707Apr 17, 2024Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist5
EP1907037Sep 7, 2022Medicament Dispenser1
EP2005372May 18, 2022Counter For Use With A Medicament Dispenser1
EP3199164Mar 18, 2020Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom1
EP2400950May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)Phenol8
EP2506844Dec 20, 2017Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist3
EP2512491Oct 11, 2017Hbv Antisense Inhibitors1

Top competitors of Glaxo Group